Neimeth International Pharmaceuticals on Wednesday published its Audited Financial Statement for the 12 months ended 30 September 2021. The result shows year on year growth in the Company’s topline and bottom line figures.
A turnover of N3.047 billion was reported for the 12 months period, up by 7.31% from N2.839 billion reported the previous year.
Profit after tax grew year on year by 27.34% to N270.576 million from N212.476 million reported the previous year.
Earnings per share (EPS) of the company stands at 14 kobo, up by 27.34% from the EPS of 11 kobo reported the previous year.
At the share price of N1.75, the P.E ratio of Neimeth International Pharmaceuticals stands at 12.28x with earnings yield of 8.14%.